Literature DB >> 14581256

Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.

Kris L L Movig1, Michiel W H E Janssen, Jan de Waal Malefijt, Peter J Kabel, Hubert G M Leufkens, Antoine C G Egberts.   

Abstract

BACKGROUND: Several reports of various bleeding problems associated with the use of serotonergic antidepressants have been published. However, no information concerning the effect of these drugs on perioperative blood loss and blood transfusion requirements during orthopedic surgery is available. The objective of this study was to determine the association between use of serotonergic antidepressants and perioperative blood loss and transfusion in orthopedic surgical patients.
METHODS: A retrospective follow-up study, using routinely collected hospital and pharmacy data, was conducted among all orthopedic patients undergoing surgery from January 1, 1999, through December 31, 2000. The actual blood transfusion requirements and blood loss during surgery were assessed. Patients were divided into 3 groups for comparison: users of serotonergic antidepressants, users of nonserotonergic antidepressants, and nonusers of antidepressants. The Medical Ethics Committee approved the study protocol, and informed consent was obtained from all patients or their legal relatives.
RESULTS: A total of 520 subjects with evaluable data participated in the study. The risk of blood transfusion almost quadrupled for the serotonergic antidepressant group as compared with the nonusers (adjusted odds ratio, 3.71; 95% confidence interval, 1.35-10.18). Patients using nonserotonergic antidepressants had no increased risk (odds ratio, 0.74; 95% confidence interval, 0.10-5.95).
CONCLUSIONS: Use of serotonergic antidepressants is associated with an increased risk of bleeding and subsequent need for blood transfusion during orthopedic surgery. The bleeding could be attributed to inhibition of serotonin-mediated platelet activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581256     DOI: 10.1001/archinte.163.19.2354

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  33 in total

Review 1.  Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

Authors:  Wei Jiang; Ranga R Krishnan
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

2.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

3.  SSRIs and gastrointestinal bleeding.

Authors:  Carol Paton; I Nicol Ferrier
Journal:  BMJ       Date:  2005-09-10

4.  Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision.

Authors:  Jie J Yao; Hilal Maradit Kremers; Walter K Kremers; David G Lewallen; Daniel J Berry
Journal:  Clin Orthop Relat Res       Date:  2018-06       Impact factor: 4.176

5.  Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control study.

Authors:  Amirali Sayadipour; Rajnish Mago; Christopher K Kepler; R Bryan Chambliss; Kenneth M Certa; Alexander R Vaccaro; Todd J Albert; D Greg Anderson
Journal:  Eur Spine J       Date:  2012-10       Impact factor: 3.134

Review 6.  [SSRI - treatment and bleeding. What risks do we take?].

Authors:  T Strubel; A Birkhofer; G Mössmer; H Förstl
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

7.  Serotonin transporter polymorphism and bleeding time during SSRI therapy.

Authors:  Dahlia M C Hougardy; Toine C G Egberts; Fedde van der Graaf; Vincent J Brenninkmeijer; Luc J J Derijks
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

8.  Selective serotonin reuptake inhibitors: measurement of effect on platelet function.

Authors:  Donna Jo McCloskey; Teodor T Postolache; Bernard J Vittone; Khanh L Nghiem; Jude L Monsale; Robert A Wesley; Margaret E Rick
Journal:  Transl Res       Date:  2007-11-20       Impact factor: 7.012

9.  Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.

Authors:  Xavier Vidal; Luisa Ibáñez; Lourdes Vendrell; Ana Conforti; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study.

Authors:  Rune Gärtner; Deirdre Cronin-Fenton; Heidi H Hundborg; Lars Pedersen; Timothy L Lash; Henrik Toft Sørensen; Niels Kroman
Journal:  BMC Surg       Date:  2010-01-24       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.